Literature DB >> 26085040

Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia.

Wenjing Zhang1, Wei Deng1, Li Yao1, Yuan Xiao1, Fei Li1, Jieke Liu1, John A Sweeney1, Su Lui1, Qiyong Gong1.   

Abstract

OBJECTIVE: This study investigated brain morphometry in chronically ill but never-medicated schizophrenia patients and whether the relation of age to morphometric abnormalities differed from that in healthy subjects.
METHOD: In a cross-sectional design, high-resolution T1-weighted images were acquired from 25 schizophrenia patients with untreated chronic illness lasting 5 to 47 years and 33 matched healthy comparison subjects. Cortical thickness and gray matter volume were compared in the two groups. In regions with significant group differences, nonlinear modeling of age-related effects was used to test for accelerated decline in the patients.
RESULTS: Schizophrenia patients had less cortical thickness in the bilateral ventromedial prefrontal cortices, left superior temporal gyrus, and right pars triangularis, relative to comparison subjects, and greater cortical thickness in the left superior parietal lobe. The relation of age to cortical thickness indicated faster age-related cortical thinning in the right ventromedial prefrontal cortex, left superior temporal gyrus, and right pars triangularis in patients than in comparison subjects, but slower thinning in the left superior parietal lobe. Gray matter volume was greater in the putamen bilaterally and smaller in the right middle temporal gyrus and right lingual gyrus of the patients, but age-related effects did not differ from those of the comparison subjects.
CONCLUSIONS: The accelerated age-related decline in prefrontal and temporal cortical thickness in never-medicated schizophrenia patients suggests a neuroprogressive process in some brain regions. Slower age-related cortical thinning of the superior parietal cortex and striatal volumetric abnormalities unrelated to age suggest different pathological processes over time in these regions.

Entities:  

Mesh:

Year:  2015        PMID: 26085040     DOI: 10.1176/appi.ajp.2015.14091108

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  26 in total

1.  What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Authors:  Christoph U Correll; Jose M Rubio; John M Kane
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Gray matter bases of psychotic features in adult bipolar disorder: A systematic review and voxel-based meta-analysis of neuroimaging studies.

Authors:  Xiuli Wang; Fangfang Tian; Song Wang; Bochao Cheng; Lihua Qiu; Manxi He; Hongming Wang; Mingjun Duan; Jing Dai; Zhiyun Jia
Journal:  Hum Brain Mapp       Date:  2018-08-10       Impact factor: 5.038

3.  Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning.

Authors:  Ganesh B Chand; Dominic B Dwyer; Guray Erus; Aristeidis Sotiras; Erdem Varol; Dhivya Srinivasan; Jimit Doshi; Raymond Pomponio; Alessandro Pigoni; Paola Dazzan; Rene S Kahn; Hugo G Schnack; Marcus V Zanetti; Eva Meisenzahl; Geraldo F Busatto; Benedicto Crespo-Facorro; Christos Pantelis; Stephen J Wood; Chuanjun Zhuo; Russell T Shinohara; Haochang Shou; Yong Fan; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite; Nikolaos Koutsouleris; Daniel H Wolf; Christos Davatzikos
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

4.  The neurobiology of transition to psychosis: clearing the cache.

Authors:  Lena Palaniyappan; Tushar Das; Kara Dempster
Journal:  J Psychiatry Neurosci       Date:  2017-09       Impact factor: 6.186

5.  Functional brain networks in never-treated and treated long-term Ill schizophrenia patients.

Authors:  Li Yao; Fei Li; Jieke Liu; Wei Liao; Xiaojing Li; Mingli Li; Yajing Meng; Sugai Liang; Chengcheng Zhang; Xiao Yang; Qiang Wang; Xiaohong Ma; Wanjun Guo; John A Sweeney; Qiyong Gong; Su Lui; Wei Deng; Tao Li
Journal:  Neuropsychopharmacology       Date:  2019-06-04       Impact factor: 7.853

6.  Deviation from expected cognitive ability across psychotic disorders.

Authors:  W C Hochberger; T Combs; J L Reilly; J R Bishop; R S E Keefe; B A Clementz; M S Keshavan; G D Pearlson; C A Tamminga; S K Hill; J A Sweeney
Journal:  Schizophr Res       Date:  2017-05-22       Impact factor: 4.939

7.  Multi-scale semi-supervised clustering of brain images: Deriving disease subtypes.

Authors:  Junhao Wen; Erdem Varol; Aristeidis Sotiras; Zhijian Yang; Ganesh B Chand; Guray Erus; Haochang Shou; Ahmed Abdulkadir; Gyujoon Hwang; Dominic B Dwyer; Alessandro Pigoni; Paola Dazzan; Rene S Kahn; Hugo G Schnack; Marcus V Zanetti; Eva Meisenzahl; Geraldo F Busatto; Benedicto Crespo-Facorro; Romero-Garcia Rafael; Christos Pantelis; Stephen J Wood; Chuanjun Zhuo; Russell T Shinohara; Yong Fan; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite; Nikolaos Koutsouleris; Daniel H Wolf; Christos Davatzikos
Journal:  Med Image Anal       Date:  2021-11-11       Impact factor: 8.545

Review 8.  Psychoradiology: The Frontier of Neuroimaging in Psychiatry.

Authors:  Su Lui; Xiaohong Joe Zhou; John A Sweeney; Qiyong Gong
Journal:  Radiology       Date:  2016-11       Impact factor: 11.105

9.  An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers.

Authors:  Peter C T Hawkins; Tobias C Wood; Anthony C Vernon; Alessandro Bertolino; Fabio Sambataro; Juergen Dukart; Emilio Merlo-Pich; Celine Risterucci; Hanna Silber-Baumann; Eamonn Walsh; Ndabezinhle Mazibuko; Fernando O Zelaya; Mitul A Mehta
Journal:  Hum Brain Mapp       Date:  2017-10-23       Impact factor: 5.038

10.  Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions.

Authors:  Hayley F North; Jason Bruggemann; Vanessa Cropley; Vaidy Swaminathan; Suresh Sundram; Rhoshel Lenroot; Avril M Pereira; Andrew Zalesky; Chad Bousman; Christos Pantelis; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-24       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.